Timothy Shannon

Dr. Timothy M.
Shannon, MD, is a Chairman at Arvinas Operations, Inc., a Managing Member at Canaan Partners X LLC, a Managing Member at Canaan Partners XI LLC, a Member at Canaan Partners IX LLC, a General Partner at Canaan Management, Inc. and a Chairman at Halda Therapeutics OpCo, Inc. He is on the Board of Directors at Rallybio Holdings LLC, Rallybio LLC and Vivace Therapeutics, Inc. Dr. Shannon was previously employed as an Independent Director by Rallybio Corp., a Chairman by IDEAYA Biosciences, Inc., an Independent Director by NextCure, Inc., a Chairman by Arvinas, Inc., an Independent Director by CytomX Therapeutics, Inc., a President, Chief Executive Officer & Director by Aldea Pharmaceuticals, Inc., a President, Chief Executive Officer & Director by CuraGen Corp., a Senior VP-Worldwide Clinical Development by Bayer HealthCare, a Senior VP-Global Medical Development by Bayer Corp., a Chairman by Spyryx Biosciences, Inc., and an Assistant Professor by Yale School of Medicine.
He also served on the board at Novira Therapeutics LLC, Civitas Therapeutics, Inc., Celldex Therapeutics, Inc., CytomX Therapeutics Holdings LLC and VaxInnate Corp.
He received his undergraduate degree from Amherst College and a doctorate degree from The University of Connecticut School of Medicine.